Price$0.67-0.00 (-0.13%)
2026-03-042026-06-05
News · 26 weeks13-100%
2025-12-142026-06-07
Mix1190d
- SEC Filings8(73%)
- Other2(18%)
- Dividends1(9%)
Latest news
25 items- SECRetractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- SECSEC Form 10-Q filed by Retractable Technologies Inc.10-Q - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- SECRetractable Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- SECRetractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- PRRetractable Technologies, Inc. Announces Workforce ReductionRetractable Technologies, Inc. (NYSE:RVP) reports that it has reduced its workforce by approximately 16%. The reduction is expected to save an estimated $2.2 million in annual wages and employment benefits, or approximately 13% of total estimated workforce costs. The expected savings are offset by estimated one-time separation payments of approximately $122 thousand to the affected workers. Approximately 58% of the targeted payroll reduction affects manufacturing or manufacturing support positions and the remainder of the reductions affects sales and sales support roles. The move comes as the Company continues to strengthen its domestic production capabilities and increase manufacturing e
- SECRetractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- PRRetractable Technologies, Inc. Reports Results for 2025Retractable Technologies, Inc. (NYSE:RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission. The Company's revenues for 2025 increased 15.8%. The Company's revenues were approximately $38.3 million in 2025 as compared to approximately $33.0 million in the prior year. Domestic revenues increased 9.7% principally due to an increase in VanishPoint® and EasyPoint® needle sales. International revenues increased 64.0% predominantly due to higher EasyPoint® needle sales. Compar
- PRRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersRetractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2026 through March 31, 2026. The dividends will be paid on April 20, 2026 to shareholders of record as of the close of business on April 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cath
- SECSEC Form 10-K filed by Retractable Technologies Inc.10-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- SECSEC Form DEFA14A filed by Retractable Technologies Inc.DEFA14A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- SECSEC Form DEF 14A filed by Retractable Technologies Inc.DEF 14A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- SECRetractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- PRRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersRetractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2025 through December 31, 2025. The dividends will be paid on January 20, 2026 to shareholders of record as of the close of business on January 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $4,424 worth of shares (5,731 units at $0.77), increasing direct ownership by 0.04% to 15,831,222 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
- SECRetractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- PRRetractable Technologies, Inc. Results for the Periods Ended September 30, 2025Retractable Technologies, Inc. (NYSE:RVP) reports total net sales of $10.1 million for the third quarter of 2025 and an operating loss of $3.7 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $5.1 million. For the first nine months of the year, net sales were $28.8 million and operating losses were $13.5 million as compared to 2024 net revenues of $24.0 million and operating losses of $13.9 million. Tariffs continue to have a material impact on our results of operation and financial position. The tariff rate on needles and syringes imported from China as of September 30, 2025 was 130% and the rate on other produ
- PRRetractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with NeedleRetractable Technologies, Inc. (NYSE:RVP) announces its EasyPoint® Blood Collection Tube Holder with Needle has received an Innovative Technology designation from Vizient®, the largest healthcare performance improvement company in the country. Each year, healthcare experts serving on one of Vizient's client-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of he
- SECSEC Form 10-Q filed by Retractable Technologies Inc.10-Q - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $81 worth of shares (100 units at $0.81), increasing direct ownership by 0.00% to 15,825,491 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $6,195 worth of shares (7,500 units at $0.83), increasing direct ownership by 0.05% to 15,825,391 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $12,915 worth of shares (15,000 units at $0.86), increasing direct ownership by 0.09% to 15,817,891 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $32,028 worth of shares (35,000 units at $0.92), increasing direct ownership by 0.22% to 15,802,891 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $32,522 worth of shares (34,506 units at $0.94), increasing direct ownership by 0.22% to 15,767,891 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $339 worth of shares (356 units at $0.95), increasing direct ownership by 0.00% to 15,733,385 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
- INSIDERPRESIDENT AND CEO Shaw Thomas J bought $9,600 worth of shares (10,000 units at $0.96), increasing direct ownership by 0.06% to 15,733,029 units (SEC Form 4)4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
RVP FAQ
6 questionsWhat does Retractable Technologies Inc. do?
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and...Where does RVP stock trade?
Retractable Technologies Inc. (RVP) is listed on AMEX.What sector and industry is RVP in?
Retractable Technologies Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Retractable Technologies Inc. go public?
Retractable Technologies Inc. (RVP) completed its IPO in 2001.What companies are similar to RVP?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare RVP side-by-side with any of them on Quantisnow.How can I track RVP on Quantisnow?
Quantisnow aggregates Retractable Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RVP to receive live email and push alerts on every new disclosure.